Health spending: Boomers will spike costs, but growing uninsured will soften their impactFebruary 20, 2019Business of Medicine
ICYMI: Rivaroxaban reduces VTE incidence in ambulatory cancer patientsFebruary 20, 2019ThrombosisPatient & Survivor Care
McAneny: Transparency needed for meaningful talk on drug pricingFebruary 20, 2019Business of Medicine